These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


239 related items for PubMed ID: 8157704

  • 1. Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women.
    Marcocci C, Golia F, Bruno-Bossio G, Vignali E, Pinchera A.
    J Clin Endocrinol Metab; 1994 Apr; 78(4):818-23. PubMed ID: 8157704
    [Abstract] [Full Text] [Related]

  • 2. Skeletal integrity in men chronically treated with suppressive doses of L-thyroxine.
    Marcocci C, Golia F, Vignali E, Pinchera A.
    J Bone Miner Res; 1997 Jan; 12(1):72-7. PubMed ID: 9240728
    [Abstract] [Full Text] [Related]

  • 3. A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre.
    De Rosa G, Testa A, Maussier ML, Callà C, Astazi P, Albanese C.
    Horm Metab Res; 1995 Nov; 27(11):503-7. PubMed ID: 8770627
    [Abstract] [Full Text] [Related]

  • 4. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
    Chen CH, Chen JF, Yang BY, Liu RT, Tung SC, Chien WY, Lu YC, Kuo MC, Hsieh CJ, Wang PW.
    J Formos Med Assoc; 2004 Jun; 103(6):442-7. PubMed ID: 15278189
    [Abstract] [Full Text] [Related]

  • 5. Effect of TSH-suppressive doses of levothyroxine on bone mineral density in Thai women.
    Ongphiphadhanakul B, Puavilai G, Rajatanavin R.
    J Med Assoc Thai; 1996 Sep; 79(9):563-7. PubMed ID: 8996984
    [Abstract] [Full Text] [Related]

  • 6. Bone mineral density in premenopausal women receiving levothyroxine suppressive therapy.
    Nuzzo V, Lupoli G, Esposito Del Puente A, Rampone E, Carpinelli A, Del Puente AE, Oriente P.
    Gynecol Endocrinol; 1998 Oct; 12(5):333-7. PubMed ID: 9859026
    [Abstract] [Full Text] [Related]

  • 7. Effects of suppressive doses of levothyroxine treatment on sex-hormone-binding globulin and bone metabolism.
    Lecomte P, Lecureuil N, Osorio-Salazar C, Lecureuil M, Valat C.
    Thyroid; 1995 Feb; 5(1):19-23. PubMed ID: 7787428
    [Abstract] [Full Text] [Related]

  • 8. Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine.
    Karner I, Hrgović Z, Sijanović S, Buković D, Klobucar A, Usadel KH, Fassbender WJ.
    Eur J Med Res; 2005 Nov 16; 10(11):480-8. PubMed ID: 16354602
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Global skeletal uptake of technetium-99m methylene diphosphonate in female patients receiving suppressive doses of L-thyroxine for differentiated thyroid cancer.
    Frusciante V, Carnevale V, Scillitani A, Zingrillo M, Dicembrino F, Giannatempo GM, Ghiggi MR, Minisola S.
    Eur J Nucl Med; 1998 Feb 16; 25(2):139-43. PubMed ID: 9473261
    [Abstract] [Full Text] [Related]

  • 16. Prevention of bone loss induced by thyroxine suppressive therapy in postmenopausal women: the effect of calcium and calcitonin.
    Kung AW, Yeung SS.
    J Clin Endocrinol Metab; 1996 Mar 16; 81(3):1232-6. PubMed ID: 8772604
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Changes of bone mineral density in pre-menopausal women with differentiated thyroid cancer receiving L-thyroxine suppressive therapy.
    Mazokopakis EE, Starakis IK, Papadomanolaki MG, Batistakis AG, Papadakis JA.
    Curr Med Res Opin; 2006 Jul 16; 22(7):1369-73. PubMed ID: 16834835
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.